Ocular Therapeutix, Inc.

📍 Bedford, United States🗓 Founded 2006👥 258 employees💰 Last funded 2012
Pharmaceutical Manufacturing🌐 ocutx.com
Website LinkedIn
Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology. Our robust product pipeline positions Ocular Therapeutix to become a leader in the ophthalmic space due to our ability to create drug delivery solutions that reduce the complexity and burden of the current standard of care by developing sustained release alternatives. With a focus on advancing our products through to Phase 3 clinical trials, our intention is to develop a commercially viable portfolio to overcome the issues of patient compliance and adherence by providing means of more consistent and reliable drug dosing for better patient outcomes.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2006
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Ocular Therapeutix, Inc. last raise funding?
The most recent investment in Ocular Therapeutix, Inc. recorded on gritt.io was in 2012.
When was Ocular Therapeutix, Inc. founded?
Ocular Therapeutix, Inc. was founded in 2006.
What industry is Ocular Therapeutix, Inc. in?
Ocular Therapeutix, Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Ocular Therapeutix, Inc. based?
Ocular Therapeutix, Inc. is headquartered in Bedford, United States.